SPM, JLT and AR contributed to the study design and to the development of the proposal. All authors read and approved the final manuscript. Corresponding author Correspondence to Morten Pallisgaard Støve. Ethics declarations Ethics approval and consent to participate The trial is approved by The ...
In the present work, all SPM were solid tumors with an incidence of 5.4%. This incidence was lower than the recent statistical results from a large cohort analysis of adult patients, in which, the 5-year estimated incidence of second solid tumor was 15.2% and the median onset was 2.2 year...
Trial registration The trial was approved by Swissmedic (Registration Number: 10001035, 08/22/2022) and the Ethics Committee of Bern (Registration Number: 2022-D0036, 08/22/2022). The trial was registered at ClinicalTrials.gov NCT05934019 on 07–03-2023. View this article's peer review repor...
Trial registration The trial was approved by Swissmedic (Registration Number: 10001035, 08/22/2022) and the Ethics Committee of Bern (Registration Number: 2022-D0036, 08/22/2022). The trial was registered at ClinicalTrials.gov NCT05934019 on 07–03-2023. Peer Review reports Administrative inform...
All data will be analysed with SPM12 and FSL. The EEG assessment (Vancouver site only) is performed using a 64-channel Hydrogel Geodesic SensorNets (EGI, Eugene, OR). Five minutes of resting data are collected while participants have their eyes closed. Participants then perform a 25-min ...
white matter lesions are segmented and quantified from FLAIR images with the lesion growth algorithm implemented in the lesion segmentation toolbox in the open source statistical parametric modelling software (SPM). Perivascular space dilation and lacunes are inspected from T2-weighted and FLAIR images,...